메뉴 건너뛰기




Volumn 12, Issue 1, 2007, Pages 33-43

A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and self-antigens in cancer patients

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CANCER VACCINE; CARBOPLATIN; GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HYDROXYAPATITE; IMMUNOLOGICAL ADJUVANT; MEMBRANE PROTEIN; TEMOZOLOMIDE; TUMOR ANTIGEN;

EID: 34250859071     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1379/CSC-218R.1     Document Type: Article
Times cited : (45)

References (39)
  • 1
    • 4644335916 scopus 로고    scopus 로고
    • Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma
    • s
    • Atkins MB, Regan M, McDermott D. 2004. Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma. Clin Cancer Res 10: 6342s-6346s.
    • (2004) Clin Cancer Res , vol.10
    • Atkins, M.B.1    Regan, M.2    McDermott, D.3
  • 2
    • 4644354179 scopus 로고    scopus 로고
    • Dendritic cell-tumor vaccines for renal cell carcinoma
    • s
    • Avigan D. 2004. Dendritic cell-tumor vaccines for renal cell carcinoma. Clin Cancer Res 10: 6347s-6352s.
    • (2004) Clin Cancer Res , vol.10
    • Avigan, D.1
  • 3
    • 0037108696 scopus 로고    scopus 로고
    • Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: Clinical and immunologic findings
    • Belli F, Testori A, Rivoltini L, et al. 2002. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J Clin Oncol 20: 4169-4180.
    • (2002) J Clin Oncol , vol.20 , pp. 4169-4180
    • Belli, F.1    Testori, A.2    Rivoltini, L.3
  • 5
    • 21744445069 scopus 로고    scopus 로고
    • Heat shock proteins in cancer: Diagnostic, prognostic, predictive and treatment implications
    • Ciocca DR, Calderwood SK. 2005. Heat shock proteins in cancer: diagnostic, prognostic, predictive and treatment implications. Cell Stress Chaperones 10: 86-103.
    • (2005) Cell Stress Chaperones , vol.10 , pp. 86-103
    • Ciocca, D.R.1    Calderwood, S.K.2
  • 9
    • 0030951877 scopus 로고    scopus 로고
    • bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: A Southwest oncology group study
    • Elledge RM, Green S, Howes L, et al. 1997. bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest oncology group study. J Clin Oncol 15: 1916-1922.
    • (1997) J Clin Oncol , vol.15 , pp. 1916-1922
    • Elledge, R.M.1    Green, S.2    Howes, L.3
  • 11
    • 0141720783 scopus 로고    scopus 로고
    • Cancer vaccines: Between the idea and the reality
    • Fin OJ. 2003. Cancer vaccines: between the idea and the reality. Nat Rev Immunol 3: 630-641.
    • (2003) Nat Rev Immunol , vol.3 , pp. 630-641
    • Fin, O.J.1
  • 13
  • 14
  • 15
    • 0001757686 scopus 로고
    • In vivo degradation of calcium phosphate ceramics
    • Frayssinet P, Rouquet N, Tourenne F, et al. 1994. In vivo degradation of calcium phosphate ceramics. Cells Mater 4: 383-394.
    • (1994) Cells Mater , vol.4 , pp. 383-394
    • Frayssinet, P.1    Rouquet, N.2    Tourenne, F.3
  • 16
    • 0036570609 scopus 로고    scopus 로고
    • Dendritic-cell-based anticancer vaccination: Has it matured?
    • Fukao T. 2002. Dendritic-cell-based anticancer vaccination: has it matured? Trends Immunol 23: 231-232.
    • (2002) Trends Immunol , vol.23 , pp. 231-232
    • Fukao, T.1
  • 17
    • 0032457154 scopus 로고    scopus 로고
    • Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients
    • Gago FE, Tello OM, Diblasi AM, Ciocca DR. 1998. Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients. J Steroid Biochem Mol Biol 67: 431-437.
    • (1998) J Steroid Biochem Mol Biol , vol.67 , pp. 431-437
    • Gago, F.E.1    Tello, O.M.2    Diblasi, A.M.3    Ciocca, D.R.4
  • 18
    • 0043268854 scopus 로고    scopus 로고
    • Understanding the cell biology of antigen presentation: The dendritic cell contribution
    • Gatti E, Pierre P. 2003. Understanding the cell biology of antigen presentation: the dendritic cell contribution. Curr Opin Cell Biol 15: 468-473.
    • (2003) Curr Opin Cell Biol , vol.15 , pp. 468-473
    • Gatti, E.1    Pierre, P.2
  • 19
    • 33646396792 scopus 로고    scopus 로고
    • Optimization of a self antigen for presentation of multiple epitopes in cancer immunity
    • Guevara-Patino JA, Engelhorn ME, Turk MJ, et al. 2006. Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. J Clin Invest 116: 1382-1390.
    • (2006) J Clin Invest , vol.116 , pp. 1382-1390
    • Guevara-Patino, J.A.1    Engelhorn, M.E.2    Turk, M.J.3
  • 20
    • 0031400317 scopus 로고    scopus 로고
    • Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome
    • Herr HW. 1997. Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome. Br J Urol 80: 762-765.
    • (1997) Br J Urol , vol.80 , pp. 762-765
    • Herr, H.W.1
  • 21
    • 33744940000 scopus 로고    scopus 로고
    • Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: Importance of the therapeutic effectiveness of cell transfer immunotherapy
    • Huang J, Kerstann KW, Ahmadzadeh M, Li YF, El-Gamil M, Rosenberg SA, Robins PF. 2006. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance of the therapeutic effectiveness of cell transfer immunotherapy. J Immunol 176: 7726-7735.
    • (2006) J Immunol , vol.176 , pp. 7726-7735
    • Huang, J.1    Kerstann, K.W.2    Ahmadzadeh, M.3    Li, Y.F.4    El-Gamil, M.5    Rosenberg, S.A.6    Robins, P.F.7
  • 22
    • 34548644094 scopus 로고
    • Membrane receptors: Criteria and selected methods of study
    • ed Hughes MR, Schrader WT, O'Malley BW. Baylor College of Medicine, Houston, TX
    • Iyengar R, Rojas F, Rich KA, Birnbaumer L. 1991. Membrane receptors: criteria and selected methods of study. In: Hormone Action and Molecular Endocrinology, ed Hughes MR, Schrader WT, O'Malley BW. Baylor College of Medicine, Houston, TX, 3-18.
    • (1991) Hormone Action and Molecular Endocrinology , pp. 3-18
    • Iyengar, R.1    Rojas, F.2    Rich, K.A.3    Birnbaumer, L.4
  • 23
    • 0033915289 scopus 로고    scopus 로고
    • Dix ans de thérapie génique: Déceptions et espoirs
    • Kahn A. 2000. Dix ans de thérapie génique: déceptions et espoirs. Biofutur 202: 16-21.
    • (2000) Biofutur , vol.202 , pp. 16-21
    • Kahn, A.1
  • 25
  • 27
    • 21344459458 scopus 로고    scopus 로고
    • Therapeutic vaccination in patients with gastrointestinal malignancies: A review of immunological and clinical results
    • Mosolits S, Ullenhag G, Mellstedt H. 2005. Therapeutic vaccination in patients with gastrointestinal malignancies: a review of immunological and clinical results. Ann Oncol 16: 847-862.
    • (2005) Ann Oncol , vol.16 , pp. 847-862
    • Mosolits, S.1    Ullenhag, G.2    Mellstedt, H.3
  • 28
    • 12744269479 scopus 로고    scopus 로고
    • The messenger and the message: Gp96 (GRP94)-peptide interactions in cellular immunity
    • Nicchitta CV, Carrick DM, Baker-LePain JC. 2004. The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity. Cell Stress Chaperones 9: 325-331.
    • (2004) Cell Stress Chaperones , vol.9 , pp. 325-331
    • Nicchitta, C.V.1    Carrick, D.M.2    Baker-LePain, J.C.3
  • 30
    • 4644324025 scopus 로고    scopus 로고
    • Cancer immunotherapy: Moving beyond current vaccines
    • Rosenberg SA, Yang JC, Restifo NP. 2004. Cancer immunotherapy: moving beyond current vaccines. Nat Med 10: 909-915.
    • (2004) Nat Med , vol.10 , pp. 909-915
    • Rosenberg, S.A.1    Yang, J.C.2    Restifo, N.P.3
  • 31
    • 0032471712 scopus 로고    scopus 로고
    • Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: Identification of the antigens mediating response
    • Rosenberg SA, Yang JC, White DE, Steinberg SM. 1998. Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann Surg 228: 307-319.
    • (1998) Ann Surg , vol.228 , pp. 307-319
    • Rosenberg, S.A.1    Yang, J.C.2    White, D.E.3    Steinberg, S.M.4
  • 32
    • 33646841470 scopus 로고    scopus 로고
    • Immunostimulatory colloidal delivery systems for cancer vaccines
    • Saupe A, McBurney W, Rades T, Hook S. 2006. Immunostimulatory colloidal delivery systems for cancer vaccines. Expert Opin Drug Deliv 3: 345-354.
    • (2006) Expert Opin Drug Deliv , vol.3 , pp. 345-354
    • Saupe, A.1    McBurney, W.2    Rades, T.3    Hook, S.4
  • 33
    • 0034328883 scopus 로고    scopus 로고
    • Immunotherapy of human cancer: Lessons from mice
    • Srivastava P. 2000. Immunotherapy of human cancer: lessons from mice. Nat Immunol 1: 363-366.
    • (2000) Nat Immunol , vol.1 , pp. 363-366
    • Srivastava, P.1
  • 34
    • 0023179915 scopus 로고
    • Comparison of the effects of three different treatment regimens of recombinant interferons (r-IFN alpha, r-IFN gamma, and r-IFNalpha + cimetidine) in disseminated malignant melanoma
    • Steiner A, Wolf C, Pehamberger H. 1987. Comparison of the effects of three different treatment regimens of recombinant interferons (r-IFN alpha, r-IFN gamma, and r-IFNalpha + cimetidine) in disseminated malignant melanoma. J Cancer Res Clin Oncol 113: 459-465.
    • (1987) J Cancer Res Clin Oncol , vol.113 , pp. 459-465
    • Steiner, A.1    Wolf, C.2    Pehamberger, H.3
  • 35
    • 0035503010 scopus 로고    scopus 로고
    • Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor
    • Tso CL, Zisman A, Pantuck A, et al. 2001. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Cancer Res 61: 7925-7933.
    • (2001) Cancer Res , vol.61 , pp. 7925-7933
    • Tso, C.L.1    Zisman, A.2    Pantuck, A.3
  • 37
    • 0037431540 scopus 로고    scopus 로고
    • Wang XY, Kazim L, Repasky EA, Subject JR. 2003. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease. Int J Cancer 105: 226-231.
    • Wang XY, Kazim L, Repasky EA, Subject JR. 2003. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease. Int J Cancer 105: 226-231.
  • 38
    • 4644229716 scopus 로고    scopus 로고
    • Bevacizumab for patients with metastatic renal cancer: An update
    • s
    • Yang JC. 2004. Bevacizumab for patients with metastatic renal cancer: an update. Clin Cancer Res 10: 6367s-6370s.
    • (2004) Clin Cancer Res , vol.10
    • Yang, J.C.1
  • 39
    • 3142692559 scopus 로고    scopus 로고
    • Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
    • Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ. 2004. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 64: 4973-4979.
    • (2004) Cancer Res , vol.64 , pp. 4973-4979
    • Yu, J.S.1    Liu, G.2    Ying, H.3    Yong, W.H.4    Black, K.L.5    Wheeler, C.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.